NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
James Thaventhiran
University of Cambridge - Cambridge / United Kingdom
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1368929
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
James Thaventhiran's MOST POPULAR ARTICLES
1-)
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2DA Collier, IATM Ferreira, P Kotagiri, RP Datir, EY Lim, E Touizer, B Meng, ...Nature 596 (7872), 417-422, 20213742021
2-)
Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal diseaseKJ Carss, G Arno, M Erwood, J Stephens, A Sanchis-Juan, S Hull, K Megy, ...The American Journal of Human Genetics 100 (1), 75-90, 20173262017
3-)
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild diseaseL Bergamaschi, F Mescia, L Turner, AL Hanson, P Kotagiri, BJ Dunmore, ...Immunity 54 (6), 1257-1275. e8, 20212792021
4-)
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ...Cell 184 (23), 5699-5714. e11, 20213042021
5-)
The evolution of cellular deficiency in GATA2 mutationRE Dickinson, P Milne, L Jardine, S Zandi, SI Swierczek, N McGovern, ...Blood, The Journal of the American Society of Hematology 123 (6), 863-874, 20142382014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept